Charles & Colvard (CTHR) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
1 Dec, 2025Executive summary
Annual Meeting scheduled for October 13, 2025, to elect five directors, ratify the auditor, and hold advisory votes on executive compensation and its voting frequency.
Board recommends voting for its nominees and not for those proposed by RiverStyx Capital Management or Duc Pham.
Recent financing secured through a $2 million convertible note with Ethara Capital LLC to support business operations and avoid bankruptcy.
Board and management changes include the addition of Ruten Bhanderi and James Tu in July 2025.
Voting matters and shareholder proposals
Proposals include electing five directors, ratifying BDO USA, P.C. as auditor, approving executive compensation, and determining the frequency of future say-on-pay votes.
Board recommends voting for its five nominees and for annual say-on-pay votes.
Shareholder proposals for the next annual meeting must be received by June 15, 2026.
Shareholders may nominate directors following specific bylaw procedures and deadlines.
Board of directors and corporate governance
Board consists of five nominees with diverse backgrounds in finance, operations, and industry leadership.
Two directors are considered independent under OTCX standards.
Board leadership is separated between the CEO and Chairman roles.
Board met 42 times in fiscal 2025; all directors attended at least 75% of meetings.
Standing committees include Audit, Compensation, and Nominating and Governance, each with defined responsibilities and independent members.
Stock ownership guidelines require non-management directors to hold shares equal to at least 0.5 times their annual retainer.
Latest events from Charles & Colvard
- Court-ordered annual meeting set for October 13, 2025, with limited agenda and board elections.CTHR
Proxy Filing1 Dec 2025 - Shareholders face a contested Board election and key governance votes amid ongoing financial challenges.CTHR
Proxy Filing1 Dec 2025 - Director nominations by a shareholder were invalidated; Board to recommend elections at the Annual Meeting.CTHR
Proxy Filing1 Dec 2025 - Proxy contest seeks to replace four directors to address financial and governance concerns.CTHR
Proxy Filing1 Dec 2025 - Shareholders face a contested Board election amid calls for leadership change and strategic overhaul.CTHR
Proxy Filing1 Dec 2025 - Riverstyx seeks board control with three nominees and challenges a dilutive stock issuance.CTHR
Proxy Filing1 Dec 2025 - FY2024 saw a 27% sales decline, $14.4M loss, and major liquidity risks for Charles & Colvard.CTHR
Q4 202430 Sep 2025